Loading chat...
MD SB875
Bill
Status
Introduced
2/3/2025
Primary Sponsor
William Folden
Click for details
AI Summary
-
Retailers may only sell medetomidine or xylazine products to purchasers who provide proof of institutional, veterinary, or scientific purpose, and all buyers must be at least 21 years old
-
Retailers must maintain records of all sales, including copies of age verification identification and documentation of the purchaser's intended use
-
Civil penalties for violations are $3,000 for a first offense and $6,500 for each subsequent violation
-
All collected civil penalties must be deposited into the Maryland Substance Abuse Fund
-
Effective date: October 1, 2025
Legislative Description
Public Health – Medetomidine and Xylazine Consumer Protection Act
Records
Last Action
Hearing 3/11 at 1:00 p.m.
3/4/2025
Committee Referrals
Finance2/3/2025
Full Bill Text
No bill text available